Monitoring neutrophil phagocytosis in lung cancer patients or normal stem cell donors, treated with G-CSF.
Lawry
J
J
Institute for Cancer Studies, University Medical School, Sheffield.
Smith
M O
MO
Lorigan
P C
PC
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006412:Hematopoietic Stem Cells; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000628:therapy*; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D010587:Phagocytosis / Q000187:drug effects*; D012016:Reference Values; D014019:Tissue Donors
D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor